Skip to main content
. 2025 Nov 14;13(4):269. doi: 10.3390/medsci13040269
AC Adenylate Cyclase
ACE Angiotensin-Converting Enzyme
ADA American Diabetes Association
Akt Protein Kinase B
ALT Alanine Aminotransferase
ASCVD Atherosclerotic Cardiovascular Disease
AST Aspartate Aminotransferase
cAMP Cyclic Adenosine Monophosphate
CNS Central Nervous System
COPD Chronic Obstructive Pulmonary Disease
CRMS Cardio–Renal–Metabolic Syndrome
CVOT Cardiovascular Outcome Trial
DKD Diabetic Kidney Disease
DN Diabetic Nephropathy
DPP-4 Dipeptidyl Peptidase-4
EPAC Exchange Protein Directly Activated By Camp
FDA Food And Drug Administration
GCGR Glucagon Receptor
GFR Glomerular Filtration Rate
GIP Glucose-Dependent Insulinotropic Polypeptide
GIPR GIP Receptor
GLP-1 Glucagon-Like Peptide-1
GLP-1R GLP-1 Receptor
GLP-1RA GLP-1 Receptor Agonist
GLUT-4 Glucose Transporter Type 4
GPCR G Protein-Coupled Receptor
HbA1c Glycated Hemoglobin
HDL High-Density Lipoprotein
HFpEF Heart Failure With Preserved Ejection Fraction
HSA Human Serum Albumin
IR Insulin Resistance
IRS-1 Insulin Receptor Substrate 1
LDL Low-Density Lipoprotein
MACE Major Adverse Cardiovascular Events
MASH Metabolic Dysfunction-Associated Steatohepatitis
MASLD Dysfunction-Associated Steatotic Liver Disease
MI Myocardial Infarction
NAFLD Non-Alcoholic Fatty Liver Disease
NAION Non-Arteritic Anterior Ischemic Optic Neuropathy
PEG Polyethylene Glycol
PI3K Phosphoinositide 3-Kinase
PLGA Poly(Lactic-Co-Glycolic Acid)
PKA Protein Kinase A
PKCβ Protein Kinase C Beta
PPAR-α Peroxisome Proliferator-Activated Receptor Alpha
RAAS Renin–Angiotensin–Aldosterone System
Ro5 Lipinski’s Rule Of Five
SGLT2 Sodium-Glucose Cotransporter 2
SGLT2i Sodium–Glucose Cotransporter 2 Inhibitors
SNAC Sodium N-[8-(2-Hydroxybenzoyl)Aminocaprylate]
SPPS Solid-Phase Peptide Synthesis
T2DM Type 2 Diabetes Mellitus
WHO World Health Organization
(AEEA)2 [2-(2-(2-aminoethoxy) ethoxy) acetic acid]2
(Oda)2 (2,2′-Oxydiacetic acid)2